Wellness

  • Automating inequality: When AI undervalues women’s care needs

    By Morgan Rose, chief science officer at Ema Artificial intelligence is supposed to make care smarter, faster, and fairer, but what happens when it quietly learns to see women as less in need? New research from the Care Policy and Evaluation Centre (CPEC) at the London School of Economics, led by Sam Rickman, reveals a [...]

  • Why microplastics in intimate care demand a scientific response

    Dr Olivia Ahn, founder of FLUUS The FemTech industry is rapidly innovating, but the conversation often neglects a fundamental issue: material safety. While we focus on digital tracking and advanced fabrics, the tiny, ubiquitous fragments of plastic in our personal care products, microplastics, pose a significant, yet often silent, threat to women’s intimate and systemic [...]

  • 8 ways to improve mental health access across your menstrual cycle

    Have you noticed how some weeks you feel clear-headed and energetic, while others leave you foggy, anxious, or tearful? There's a reason for that. Your mental health during PMS and across your entire menstrual cycle isn't random. It's deeply connected to how your brain responds to shifting hormone levels. Estrogen and progesterone don't just affect [...]

  • The silent wait: Why women deserve faster, specialist care

    By Dr Hisham Abouzeid, consultant in obstetrics and gynaecology, Transform Femme Across the UK, women are facing an unacceptable reality when it comes to their health. From pelvic floor problems and heavy bleeding to chronic pain and postnatal complications, millions of women are living with treatable conditions that are simply not being treated, often for [...]

  • Rem3dy Health secures £1.4m in new funding

    Midlands-founded health-tech scale-up Rem3dy Health has landed £1.4m in new funding. The announcement was made at Birmingham Tech Week, as part of their Scale-Up Summit. During the event, Founder and CEO Melissa Snover confirmed that the Amsterdam-based Borski Fund, which specialises in backing high-growth, women-led ventures, has invested £900,000 in Rem3dy Health, alongside a further [...]

  • Opinion: Not ‘just stress’ – How hormonal changes affect women’s brain function

    By Dr Louise Newson BSc(Hons) MBChB(Hons) MRCGP FRCGP DHealth Over years of studying the health of women there’s one key thing that I've come to realise; clinicians have often been missing a crucial piece of the puzzle in understanding women’s mental health and brain function. It all comes down to three hormones that deserve far [...]

  • Stockport NHS Foundation Trust ends the “silent era” with CardMedic roll-out

    Stockport NHS Foundation Trust has gone live with CardMedic across the organisation, enabling its 6,300-strong workforce to communicate more clearly and confidently with patients who face language or communication barriers. CardMedic is a digital healthcare communication platform that allows staff and patients to communicate safely and effectively irrespective of language barriers, cognitive impairment or literacy. [...]

  • Research highlights challenges faced by young women with advanced breast cancer

    Nearly half of women under 40 with advanced breast cancer have children under 18, with many facing job disruption and financial strain, new research has found. A global survey has revealed the challenges faced by young women with advanced breast cancer, with 64 per cent reporting employment disruption after diagnosis and 40 per cent incurring [...]

  • YON E Health raises €250k for its vaginal health device

    Dutch femtech startup Yon E Health has raised €250k in pre-seed funding to develop a smart vaginal health sensor that measures pH and temperature. The device will monitor key indicators linked to fertility, infection risk and reproductive wellbeing, tackling what the company says are long-standing gaps in women’s healthcare. Founded by Roswitha Verwer in 2022, [...]

  • Research reveals potential way to prevent breast cancer in pre-menopausal women

    An NHS-approved drug could be repurposed to prevent breast cancer in pre-menopausal women with a strong family history of the disease, researchers have found. Ulipristal acetate, already prescribed on the NHS for other conditions, blocks progesterone – a hormone that can drive breast cancer development – and may help lower risk in women before the [...]